France· FR:65716809
INREBIC 100 mg, gélule
A medicinal product containing dichlorhydrate de fédratinib monohydraté, registered in France by BRISTOL-MYERS SQUIBB PHARMA (IRLANDE), on the national reimbursement list.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- DICHLORHYDRATE DE FÉDRATINIB MONOHYDRATÉ
- Manufacturer
- BRISTOL-MYERS SQUIBB PHARMA (IRLANDE)
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cip133400930232620flacon(s) polyéthylène haute densité (PEHD) avec fermeture de sécurité enfant de 120 gélule(s)EUR 3.26
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Dichlorhydrate de fédratinib monohydraté in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesInrebicCelgene Corporation
- CanadaINREBICBRISTOL-MYERS SQUIBB CANADA
- CzechiaINREBICBristol-Myers Squibb Pharma EEIG, Dublin
- SpainINREBIC 100 mg CAPSULAS DURASBristol-Myers Squibb Pharma Eeig
- FinlandInrebicBristol-Myers Squibb Pharma EEIG
- United KingdomInrebic 100mg capsulesBristol-Myers Squibb Pharmaceuticals Ltd
- BelgiumInrebic 100 mgBristol-Myers Squibb Pharma
- NetherlandsInrebic 100 mg, harde capsulesBristol-Myers Squibb Pharma EEIG
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Inrebic
- Liechtenstein · Inrebic
- Norway · Inrebic
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/6a133e78-29b3-4e8e-8b4f-9c7d7df2844c GET /v1/drugs/6a133e78-29b3-4e8e-8b4f-9c7d7df2844c?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "65716809",
"date_amm": "2021-02-08",
"type_amm": "Procédure centralisée",
"numero_ue": "EU/1/20/1514",
"substance": "DICHLORHYDRATE DE FÉDRATINIB MONOHYDRATÉ",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "gélule",
"voies_administration": "orale",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about dichlorhydrate de fédratinib monohydraté.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.